Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutation.
Prandoni
P
P
Tormene
D
D
Spiezia
L
L
Pesavento
R
R
Simioni
P
P
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D005165:Factor V / Q000235:genetics*; D005500:Follow-Up Studies; D006579:Heterozygote; D006801:Humans; D008875:Middle Aged; D011516:Prothrombin / Q000235:genetics*; D055502:Secondary Prevention; D013923:Thromboembolism / Q000188:drug therapy* / Q000473:pathology; D055815:Young Adult
D000925:Anticoagulants; C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin